Lv11
60 积分 2025-08-12 加入
Efficacy and safety of first-line maintenance therapy with lurbinectedin plus atezolizumab in extensive-stage small-cell lung cancer (IMforte): a randomised, multicentre, open-label, phase 3 trial
29分钟前
已完结
Autophagy and Oxidative Stress in Solid Tumors: Mechanisms and Therapeutic Opportunities
3个月前
已关闭
Belantamab mafodotin, pomalidomide, and dexamethasone for triple class exposed/refractory relapsed multiple myeloma: a subgroup analysis of the ALGONQUIN trial
皖公网安备34019202002308
